IP Library Granted Patent US 8,517,914
Granted Patent B2
US 8,517,914 · App. 12/447,073 · Granted Aug 27, 2013

Surgical articles and methods for treating pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,517,914
App. No.
12/447,073
Granted
Aug 27, 2013
Kind
B2
Abstract

Described are pelvic implants and methods of surgically placing pelvic implants, that provide treatment for pelvic floor disorders by support of the levator.

Claims (44)

1. A pelvic implant for supporting levator tissue, the implant comprising a tissue support portion bounded by:

an anterior side extendable from an anterior region of the pelvic region to a region of medial levator tissue, the anterior region selected from a region of the obturator foramen, a region of the arcus tendineus, and a region of puborectalis muscle,

a posterior side extendable from a posterior region of the pelvic region to a region of medial levator tissue, the posterior region selected from a region of the ischial spine, an ischial tuberosity, a sacrospinous ligament, a sacrotuberous ligament, and a sacrum,

a grommet at a corner of the implant,

at least one lateral end extendable from the anterior region to the posterior region, and

fixation means comprising an anchoring element and mesh, the fixation means being passable through the grommet when the tissue support portion is located at a region of levator tissue,

wherein the tissue support portion comprises first and second opposing shaped portions, each shaped portion comprising:

a portion of the anterior side of the tissue support portion;

a portion of the posterior side of the tissue support portion, and

the at least one lateral end of the tissue support portion:

and wherein

the first and second shaped portions are connected at a medial portion,

the implant has a length in the range from 14 to 18 centimeters,

the medial portion has a dimension in the range from about 2 to 3 centimeters, and

the at least one lateral end has a length in the range from about 6 to 10 centimeters.

2. The implant of claim 1 wherein the shaped portions have a shape substantially of a figure selected from a square, a rhombus, a symmetric trapezoid, a non-symmetric trapezoid, a symmetric rectangle, and a non-symmetric rectangle.

3. The implant of claim 1 comprising one or two extension portions located at corners of the shaped portions along the at least one lateral end.

4. A kit comprising an implant according to claim 1 , the anchoring element comprising a self-fixating tip, and the kit further comprising an insertion tool that engages the self-fixating tip.

5. A kit according to claim 4 wherein the insertion tool comprises an elongate needle having a shape selected from the group consisting of: a straight form, a curve in two dimensions, a curve in three dimensions, and a helical curve.

6. A pelvic implant for supporting levator tissue, the implant comprising two opposing tissue support portions, each opposing tissue support portion comprising:

an anterior side extendable from an anterior region of the pelvic region to a region of medial levator tissue, the anterior region selected from a region of the obturator foramen, a region of the arcus tendineus, and a region of puborectalis muscle,

a posterior side extendable from a posterior region of the pelvic region to a region of medial levator tissue, the posterior region selected from a region of the ischial spine, an ischial tuberosity, a sacrospinous ligament, a sacrotuberous ligament, and a sacrum,

a grommet, and

a lateral end extendable from the anterior region to the posterior region when the two tissue support portions are located at a region of levator tissue, and wherein:

the two opposing tissue support portions are connected at a medial portion,

the implant has a length in the range from 14 to 18 centimeters,

the medial portion has a dimension in the range from about 2 to 3 centimeters, and

the lateral end has a length in the range from about 6 to 10 centimeters.

7. An implant according to claim 6 wherein the grommet is at a corner of the implant.

8. An implant according to claim 7 further comprising fixation means with an anchoring element, the fixation means being capable of passing through the grommet.

9. A kit comprising a pelvic implant for supporting levator tissue, the implant comprising two opposing tissue support portions, each opposing tissue support

portion comprising:

an anterior side extendable from an anterior region of the pelvic region to a region of medial levator tissue, the anterior region selected from a region of the obturator foramen, a region of the arcus tendineus, and a region of puborectalis muscle,

a posterior side extendable from a posterior region of the pelvic region to a region of medial levator tissue, the posterior region selected from a region of the ischial spine, an ischial tuberosity, a sacrospinous ligament, a sacrotuberous ligament, and a sacrum,

a grommet at a corner of each of the two tissue support portions,

a lateral end extendable from the anterior region to the posterior region, and

a self-fixating tip,

wherein:

the two opposing tissue support portions are connected at a medial portion,

the implant has a length in the range from 14 to 18 centimeters,

the medial portion has a dimension in the range from about 2 to 3 centimeters, and

the lateral end has a length in the range from about 6 to 10 centimeters;

the kit comprising an insertion tool that engages the self-fixating tip.

10. A kit according to claim 9 comprising fixation means capable of passing through the grommet, the fixation means comprising mesh and a self-fixating tip.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →